Siplizumab in T1DM

Clinical trial NCT05574335 · TERMINATED

Trial details

NCT number: NCT05574335
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2023-05-18
Primary completion: 2025-05-14
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.